Jin, Jing-Lu
Zhang, Hui-Wen
Cao, Ye-Xuan
Liu, Hui-Hui
Hua, Qi
Li, Yan-Fang
Zhang, Yan
Guo, Yuan-Lin
Wu, Na-Qiong
Zhu, Cheng-Gang
Xu, Rui-Xia
Gao, Ying
Li, Xiao-Lin
Cui, Chuan-Jue
Liu, Geng
Sun, Jing
Dong, Qian
Santos, Raul
Li, Jian-Jun http://orcid.org/0000-0003-2536-4364
Funding for this research was provided by:
Capital Health Development Fund (201614035)
CAMS Major Innovation Project (2016-I2M -1-011)
Article History
Received: 7 June 2020
Accepted: 12 September 2020
First Online: 27 September 2020
Ethics approval and consent to participate
: Our study complied with the Declaration of Helsinki and was approved by the hospital’s ethical review board (Fu Wai Hospital & National Center for Cardiovascular Diseases, Beijing, China). Informed written consents were obtained from all patients enrolled in this study.
: Not applicable.
: Raul D. Santos has received honoraria related to consulting, research and/or speaker activities from: Ache, Amgen, Astra Zeneca, Esperion, Kowa, Novo-Nordisk, Merck, MSD, Pfizer, PTC and Sanofi/Regeneron. All other authors declare no conflicts of interest.